Riskpilot← Back to searchSign inGet full accessLINDESNES FYSIOTERAPI AS
ASActiveOrg 916910398Spangereidveien 1, 4520 LindesnesPhysiotherapy activities · NACE 8695Est. 20161 employees
Revenue 2024
NOK 1,6M
+3% vs 2023
EBITDA margin
9.5%
-27% vs 2023
Equity ratio
2.5%
Financial strength
Net profit 2024
NOK 29K
-57% vs 2023
| Revenue | NOK 1,6M | +3% |
| EBITDA | NOK 148K | -27% |
| Net profit | NOK 29K | -57% |
| Total assets | NOK 1,2M | -1% |
| Equity | NOK 30K | -23% |
| Employees | 1 | — |
Legal name
LINDESNES FYSIOTERAPI AS
Org number
916910398
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
17. mars 2016
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drift av fysioterapivirksomhet med behandlingstjenester og annet som står i forbindelse med dette, herunder drift av eiendommer og deltakelse i andre foretak.
Address
Spangereidveien 1, 4520 Lindesnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 258 | 1 386 | 1 406 | 1 516 | 1 560 |
| Staff expenses | −697 | −827 | −888 | −936 | −1 021 |
| EBITDA | 245 | 244 | 138 | 201 | 148 |
| Depreciation & amort. | −57 | −50 | −50 | −50 | −44 |
| EBIT | 188 | 194 | 88 | 151 | 104 |
| Net financials | −46 | −38 | −46 | −66 | −67 |
| Profit before tax | 142 | 156 | 41 | 85 | 37 |
| Tax | 31 | 34 | 11 | 19 | 8 |
| Net profit | 111 | 122 | 30 | 66 | 29 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 436 | 1 366 | 1 260 | 1 228 | 1 220 |
| Equity | 35 | 37 | 38 | 39 | 30 |
| Long-term debt | 1 140 | 1 055 | 974 | 897 | 853 |
| Short-term debt | 262 | 274 | 249 | 292 | 336 |
| Total debt | 1 401 | 1 329 | 1 222 | 1 189 | 1 189 |
EBITDA margin
9.5%
This company
15.8%
Market median
-40% vs market
20202024
Equity ratio
2.5%
This company
38.2%
Market median
-93% vs market
20202024
Return on equity
94.5%
This company
18.4%
Market median
+414% vs market
20202024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20202024
Asset turnover
1.28×
This company
1.12×
Market median
+14% vs market
20202024
Debt / equity
39.25×
This company
0.62×
Market median
-6231% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NK Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nk Invest As
LINDESNES FYSIOTERAPI AS Board members of LINDESNES FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Kerim | Chief Executive Officer | 0 companies |
| Lars Ove Lindland | Board of Directors | 0 companies |